It has been suggested that the risk of coronary heart disease and myocardial infarction may be increased due to the Glu504Lys variant in the ALDH2 gene, which is responsible for reducing the ability of ALDH2 to metabolize acetaldehyde [72]. This evidence concerns the gene ALDH2 and coronary artery disorder.